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A Comparison of Inflammatory and Oxidative Stress Markers in Adipose
Tissue from Weight-Matched Obese Male and Female Mice
Abstract
Expansion of intra-abdominal adipose tissue and the accompanying inflammatory response has been put
forward as a unifying link between obesity and the development of chronic diseases. However, an apparent
sexual dimorphism exists between obesity and chronic disease risk due to differences in the distribution and
abundance of adipose tissue. A range of experimental protocols have been employed to demonstrate the role
of estrogen in regulating health benefits; however, most studies are confounded by significant differences in
body weight and adiposity. Therefore, the purpose of this study was to compare weight-matched obese male
and female mice to determine if the sex-dependent health benefits remain when body weight is similar. The
development of obesity in female mice receiving a high-fat diet was delayed; however, subsequent
comparisons of weight-matched obese mice revealed greater adiposity in obese female mice. Despite excess
adiposity and enlarged adipocyte size, obese females remained more glucose tolerant than weight-matched
male mice, and this benefit was associated with increased expression of adiponectin and reductions in
immune cell infiltration and oxidative stress in adipose tissue. Therefore, the protective benefits of estrogen
persist in the obese state and appear to improve the metabolic phenotype of adipose tissue and the individual.
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Expansion of intra-abdominal adipose tissue and the accompanying inflammatory response has been put forward as a unifying
link between obesity and the development of chronic diseases. However, an apparent sexual dimorphism exists between obesity
and chronic disease risk due to diﬀerences in the distribution and abundance of adipose tissue. A range of experimental protocols
have been employed to demonstrate the role of estrogen in regulating health benefits; however, most studies are confounded by
significant diﬀerences in body weight and adiposity. Therefore, the purpose of this study was to compare weight-matched obese
male and female mice to determine if the sex-dependent health benefits remain when body weight is similar. The development
of obesity in female mice receiving a high-fat diet was delayed; however, subsequent comparisons of weight-matched obese mice
revealed greater adiposity in obese female mice. Despite excess adiposity and enlarged adipocyte size, obese females remained
more glucose tolerant than weight-matched male mice, and this benefit was associated with increased expression of adiponectin
and reductions in immune cell infiltration and oxidative stress in adipose tissue. Therefore, the protective benefits of estrogen
persist in the obese state and appear to improve the metabolic phenotype of adipose tissue and the individual.
1. Introduction
Obesity is widely regarded as an independent risk factor for
a range of chronic diseases including type 2 diabetes and
cardiovascular disease [1, 2]. Low-grade systemic inflam-
mation has been put forward as a unifying link between
obesity and the onset of these obesity-associated diseases [3–
5]. Expansion of intra-abdominal adipose tissue is associated
with increased infiltration and activation of immune cells,
and these events are a significant contributor to the systemic
inflammation that occurs with obesity [6, 7]. While an
exact explanation for the accumulation of immune cells in
adipose tissue is unknown, one potential contributing factor
is elevated oxidative stress [8, 9]. Therefore, decreasing intra-
abdominal obesity and/or reducing adipose tissue oxidative
stress and inflammation will positively influence chronic
disease risk.
Clear sex-based diﬀerences exist in adipose tissue dis-
tribution, inflammation, and ultimately the probability of
developing a chronic disease [10–12]. Specifically, females
tend to have a higher body fat content with the fat localized
subcutaneously while males have less total body fat and
their adipose tissue predominates in the visceral region.
Furthermore, animal studies have demonstrated that diet-
induced obesity and insulin resistance occur much more
rapidly in male rodents as compared to females [13–15].
Estrogen is a major factor involved in this sexual dimorphism
as it promotes subcutaneous fat accumulation, has anti-
inflammatory properties, and is a strong regulator of appetite
and energy expenditure [10, 12, 16, 17]. To help elucidate
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the eﬀects of estrogen on obesity, adipose tissue distribution,
inflammation, and insulin resistance studies have utilized
models of ovariectomy with or without repletion of estrogen
and/or compared male and female mice provided a high-
fat diet [13–15, 18]. While the outcome measures of these
studies varied, they all clearly demonstrate a beneficial eﬀect
of estrogen. However, these studies were also confounded by
body weight diﬀerences as intact females or animals receiving
estrogen were typically smaller and had smaller adipose
tissue depots.
Therefore, the purpose of the current study was to
compare weight-matched obese male and female mice to
determine if the sex-dependent improvements in metabolic
health occur independent of diﬀerences in body weight.
Following chronic exposure to a high-fat diet, a glucose
tolerance test was performed and diﬀerences in markers for
inflammatory and oxidative stress were assessed in adipose
tissue. Our data demonstrate that glucose tolerance remains
improved in obese female mice independent of a diﬀerence
in body weight. Furthermore, despite increases in total
adiposity and gonadal adipocyte size, the obese female mice
displayed lower expression of markers for immune cells
and oxidative stress which are consistent with an improved
metabolic phenotype.
2. Methods
2.1. Animals and Animal Care. The University of Missouri
Animal Care and Use committee approved all procedures
involving mice. Animals were maintained at a controlled
temperature (22◦C) and a 12-hour light: 12-hour dark
cycle. Six-to eight-week old male and female C57BL/6 mice
were individually housed and fed either a chow (Purina
5001; 4.5 g/100 g fat) or high-fat diet (HFD; Research Diets
D12492; 35 g/100 g fat) for the duration of the experiment.
Body weight was measured weekly and mice were kept on
treatment until the average body weight of the HFD group
was 45 g. At this point, glucose tolerance testing and tissue
collection were performed on the HFD group and their age-
matched chow-fed counterparts.
2.2. Glucose Tolerance Testing. Once the HFD-fed group
reached a body weight of 45 g; a glucose tolerance test was
performed in both HFD and chow-fed animals. Following
an overnight fast, a baseline blood sample was taken from
the tail vein at time 0. Then an intraperitoneal injection of
glucose (1 g/kg BW) was administered and blood glucose
concentrations were determined using a handheld glucome-
ter at 30, 60, 90, and 120 minutes postinjection. Glucose area
under the curve (AUC) calculations were performed using
GraphPad Prism 4 software.
2.3. Tissue Collection. One week after the glucose tolerance
tests were performed, animals were fasted 10–12 hours
and blood glucose was measured via a tail nick. Animals
were then euthanized by CO2 asphyxiation followed by
exsanguination via cardiac puncture. Plasma was separated
by centrifugation, aliquoted, and frozen for future analysis.
Gonadal and subcutaneous adipose tissues were excised,
weighed, and snap frozen for gene expression analysis or
fixed for histological analysis.
2.4. Histological Analysis of Adipose Tissue. A portion of the
gonadal adipose tissue was fixed in 4% paraformaldehyde,
embedded in paraﬃn, sectioned, and stained with hema-
toxylin and eosin (H&E). Digital images were acquired with
an Olympus BX51 light microscope using an Olympus DP70
camera. Dead adipocytes were quantified by identification
of crown-like structures (CLSs) within histologic sections of
adipose tissue. The percentage of CLS present in gonadal adi-
pose tissue was calculated and used for comparison among
experimental groups. Adipocyte volume was calculated using
the cross-sectional area obtained from perimeter tracings
using Image J software (Sun Microsystems, Santa Clara, CA,
USA).
2.5. Plasma Analysis. An estradiol EIA kit (Cayman Chem-
ical Company) was used to determine fasting (overnight)
plasma estradiol concentrations of female mice.
2.6. Real-Time Quantitative PCR. Total mRNAwas extracted
from adipose using RNeasy lipid tissue kits with on-
column DNase digestion (Qiagen). Purity and concentration
were determined with a Nanodrop 1000 spectrophotometer
(Thermo Scientific). 1μg of RNA was used to synthesize
cDNA with a reverse transcriptase polymerase chain reaction
kit (Applied Biosystems) and diluted to 10ng/μL. Expression
of mRNA was determined using SYBR green qRT-PCR on
an Applied Biosystems StepOne Plus RT-PCR system. Fold
diﬀerence for gene expression was calculated using 2−ΔΔCT
using the endogenous control gene RPS-3.
2.7. Statistical Analysis. Treatment diﬀerences were analyzed
by one-way analysis of variance (ANOVA) with main eﬀect
significance set at P < 0.05. Significant main eﬀects were
followed by a Tukey’s multiple comparison test. Values are
reported as mean ± standard error.
3. Results
3.1. Onset of Obesity Is Delayed in Female Mice Receiving
High-Fat Diet. Male and female C57BL/6 J mice received
either a low-fat chow diet or a HFD. The HFD induced a
more rapid body weight gain in male mice which achieved
the target body weight of 45 g in 21 weeks, while female mice
required an additional 17 weeks of HFD to reach the same
body weight (Table 1). This experimental design ensured that
mice would be studied at a body weight associated with
established obesity and insulin resistance [6] and that body
weight would not be a confounding variable. However, due
to the delayed body weight gain in female HFD mice age
did emerge as an unaccounted for variable. Interestingly,
despite having similar body weights, the adiposity of the
female HFD mice was greater than the male HFD group
as both gonadal and subcutaneous adipose tissue masses
were significantly increased (Table 1). Fasting blood glucose
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Table 1: Characteristics of male and female C57BL/6 mice receiving a standard rodent chow or a high-fat diet (HFD).1
Male chow Male HFD Female chow Female HFD
Body weight (g) 28.8± 0.28b 45.3± 1.0a 24.8± 0.45b 46.5± 2.0a
Age2 (weeks) 21 21 38 38
Gonadal AT3 (g) 0.51± 0.28c 2.25± 0.17b 0.44± 0.05c 3.74± 0.35a
Subcutaneous AT (g) 0.32± 0.01c 2.29± 0.24b 0.27± 0.02c 3.34± 0.28a
Blood glucose (mg/dL) 99± 8b 142± 11a 108± 8b 116± 5ab
Plasma estradiol (pg/mL) — — 92.5± 1.53 92.7± 0.35
1
Data are presented as means ± SE; means with diﬀerent superscripts diﬀer P < 0.05; n = 5–8.
2Age at which the HFD-fed group reached a body weight of 45 g and metabolic testing and tissue collection occurred.
3AT; adipose tissue.
concentrations were elevated by obesity in the male mice
but not the female mice. Obesity also did not alter plasma
estradiol concentrations in the female mice (Table 1).
3.2. Obese Female Mice Have Improved Glucose Tolerance
as Compared to Weight-Matched Obese Male Mice. When
the average body weight of HFD-fed male and female
mice reached 45 g, an intraperitoneal glucose tolerance test
was performed on that experimental group and their age-
matched chow-fed counterparts. Glucose area under the
curve calculations revealed better glucose tolerance in the
female HFD group as compared to the male HFD mice
(Figure 1). This improvement is especially noteworthy since
there was no diﬀerence in body weight between these two
groups and also, the HFD females had greater total fat
mass (Table 1). Further, despite the age diﬀerence, glucose
tolerance was similar between male chow and female chow
mice (Figure 1).
3.3. Immune Cell Infiltration and Oxidative Stress Markers
Are Reduced in the Adipose Tissue of Obese Female Mice. In
order to better understand the observed glucose tolerance
diﬀerences, we characterized markers of inflammation and
oxidative stress in gonadal adipose tissue. In the current
study, gonadal adipose tissuemass was greater in female HFD
mice as compared to the male HFD group (Table 1). Consis-
tent with an increased mass of adipose tissue, relative mRNA
expression of leptin in gonadal adipose tissue was elevated in
both male HFD and female HFD groups with no diﬀerence
between genders observed (Figure 2). Interestingly, gonadal
adipose tissue mRNA expression of adiponectin was reduced
in male HFD mice but remained unchanged in female HFD
mice (Figure 2). Adiponectin expression is often correlated
with smaller adipocyte size. Therefore, gonadal adipocyte
size was quantified, and surprisingly female HFD mice
had a larger average adipocyte size as compared to male
HFD mice (Figure 3). This apparent disconnect between
adipocyte size and adiponectin expression may help explain
the improvements in glucose tolerance.
Increases in adipocyte size also are correlated with an
increased presence of immune cells in adipose tissue [6, 19].
Crown-like structures (CLSs) are clusters of proinflamma-
tory immune cells that localize to dead adipocytes within
adipose tissue [20]. Consistent with previous reports [6, 21],
gonadal adipose tissue from the male HFD group contained
elevated numbers of CLS (Figure 3). Interestingly, the pres-
ence of CLS in the gonadal adipose tissue of femaleHFDmice
was reduced by greater than 50%when compared to the male
HFD group (Figure 3). In support of this observed reduction,
mRNA expression of the macrophage markers F480 and
CD11c were also decreased in female HFD compared to male
HFDmice (Figure 4). However, there was no diﬀerence in the
relative expression of the inflammatory cytokines IL-6 and
TNF-α or the chemokine MCP-1 (Figure 4). Obesity caused
a reduction in the relative mRNA expression of eNOS inmale
HFD gonadal adipose tissue while there was no change in
the female HFD group (Figure 4). Furthermore, the oxidative
stress markers HO-1, p40phox, and prdx1 were increased
in male HFD gonadal adipose tissue, and this increase was
attenuated in gonadal adipose tissue from female HFD mice
(Figure 4). Importantly, when gonadal adipose tissue from
male chow and female chow mice was compared, adipocyte
size was smaller in female mice, but there were no diﬀerences
in any of the other variables that were measured (Figures 2, 3,
and 4). Overall, adipocyte size and adipose tissuemasses were
greater in weight-matched female HFD mice as compared to
male HFD mice. However, female HFD mice had reduced
immune cell infiltration and oxidative stress, and this may
be due, in part, to increased adiponectin expression.
Subcutaneous adipose tissue has been reported to be
metabolically diﬀerent than gonadal adipose tissue [22]
and therefore the gene expression profile of this tissue
was also investigated. Subcutaneous adipose tissue mRNA
expression of CD11c and F480 was increased in male HFD
mice as compared to the female HFD group (Figure 5).
Obesity also caused an increase in MCP-1 expression in
this tissue; however, the increase was greater in the male
HFD animals as compared to the female HFD mice. The
expression of the inflammatory cytokines IL-6 and TNF-
α was increased in both male HFD and female HFD mice
(Figure 5). Similar to the results reported for gonadal adipose
tissue, mRNA expression of oxidative stress markers in
subcutaneous adipose tissue was elevated in male HFD
mice as compared to the female HFD group (Figure 5). In
contrast to the gonadal adipose tissue, we did not observe
any diﬀerences in adiponectin expression in subcutaneous
adipose tissue (data not shown). No appreciable diﬀerences
in subcutaneous mRNA expression for any of the genes
investigated were observed between male chow and female
chow groups (Figure 5).
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Figure 1: Obese female mice (female HFD) have improved glucose
tolerance when compared to weight-matched obese male mice
(male HFD). Male and female C57BL/6 mice were fed either a
standard rodent chow or a high-fat diet (HFD) from 6 weeks of
age until the HFD-fed group achieved a body weight of 45 g. At
that time, a glucose tolerance test was performed in both chow- and
HFD-fed males (21weeks old) or females (38weeks old) and blood
glucose change over time plotted (a). Corresponding blood glucose
area under the curve (AUC) was calculated (b), data are reported as
mean± SE andmeans with diﬀerent superscripts diﬀer by P < 0.05.
n = 5–8 per group.
4. Discussion
While numerous studies have demonstrated the benefits
of estrogen in obesity prevention and chronic disease risk
management [13–17, 23], our study is novel in that weight-
matched obese male and female mice were evaluated to
determine if endogenous estrogen provides health benefits
in the obese state that are independent of body weight
diﬀerences. As observed from the circulating estradiol levels,
these female mice had not entered ovarian senescence.
Postmenopausal mice have been shown to display a more
severe obese phenotype relative to their cycling, age-matched
controls [24], further supporting that estradiol provides
protection against HFD-induced obesity and alternations in
glucose metabolism. Consistent with previous reports [13–
15], we observed that male mice were more susceptible to
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Figure 2: Adiponectin mRNA expression in gonadal adipose tissue
is reduced by obesity in male mice but not weight-matched obese
female mice. Male and female C57BL/6 mice were fed either a
standard rodent chow or a high-fat diet (HFD) from 6 weeks
of age until the HFD-fed group achieved a body weight of 45 g.
At that time, both chow- and HFD-fed males (21weeks old) or
females (38weeks old) were sacrificed and qRT PCR performed on
gonadal adipose tissue. Relative mRNA expression of adiponectin
was reduced by obesity in male mice, while obesity had no eﬀect
on adiponectin expression in female mice (a). Consistent with an
obese phenotype, mRNA expression of leptin was elevated in both
male HFD and female HFD mice (b). Data are reported as mean ±
SE; n = 5–8 per group; means with diﬀerent superscripts diﬀer by
P < 0.05.
HFD-induced obesity as compared to the female HFD group.
Therefore, we recognize that age is a potential confounding
variable that was not accounted for in the current study
design as it took 17 weeks longer for the female HFD group to
reach the target body weight of 45 g. This target body weight
was selected because it has been shown to be a period of
established obesity, adipose tissue inflammation, and insulin
resistance in male mice [6].
Regardless of the diﬀerence in age, obese female mice
had improved glucose clearance during a glucose tolerance
test as compared to weight-matched obese males. This
improvement in glucose metabolism was supported by
the observation that obesity caused an increase in fasting
blood glucose concentrations in males but not females
when compared to their chow-fed littermates. These data
demonstrate that chronic exposure to a HFD can induce an
obese phenotype in female mice; however, the development
Experimental Diabetes Research 5
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Figure 3: Obese female mice have larger adipocytes and reduced prevalence of crown-like structures in gonadal adipose tissue when
compared to weight-matched obese male mice. Male and female C57BL/6 mice were fed either a standard rodent chow or a high-fat diet
(HFD) from 6 weeks of age until the HFD-fed group achieved a body weight of 45 g. At that time, both chow- and HFD-fed males (21weeks
old) or females (38weeks old) were sacrificed and histological analysis was performed on gonadal adipose tissue. Representative H&E stains
of gonadal adipose tissue from each of the four treatment groups are presented in panel (a). Sections were used to quantify the presence
of crown-like structure (b) and to calculate average adipocyte area (c). Data are reported as mean ± SE; n = 5–8 per group; means with
diﬀerent superscripts diﬀer by P < 0.05; ∗P < 0.05; bar = 100 μM.
of insulin resistance in these animals is not as severe
as that observed in weight-matched obese male mice. In
addition, advanced age is associated with the development
of insulin resistance [25] suggesting the improvement in
glucose tolerance may have been greater if the significant
diﬀerence in age did not exist between the two groups. This
diﬀerence in age may explain why glucose tolerance was
similar between the male chow and female chow-groups
while others have reported diﬀerences in glucose tolerance
testing between chow-fed male and female mice [26].
Given the strong correlation between metabolic dysfunc-
tion in adipose tissue and impaired glucose metabolism;
we examined the adipose tissue from the four experimental
groups in an attempt to better understand the observed
improvement in glucose tolerance in obese females. The
experimental design precluded body weight diﬀerences
between male HFD and female HFD groups; however, body
fat content of the female HFD mice was greater due to
increased gonadal and subcutaneous adipose tissue mass.
This increase inmass was associated with increased adipocyte
size in the gonadal adipose tissue and is contrary to our
observation in chow-fed animals and the reports of others
studying lean animals [26]. Both increased intra-abdominal
fat mass and adipocyte size have been associated with insulin
resistance in male mice due to an increased infiltration and
activation of proinflammatory immune cells in the adipose
tissue [6, 7, 19, 27, 28]. Here we observe an apparent discon-
nect where female mice have increased adipose tissue mass
and larger adipocytes but glucose tolerance is improved.
When immune cell infiltration and activation were assessed,
we observed a reduction in the appearance of immune cells
and the formation of CLS in female HFD gonadal adipose
tissue. This correlated with reductions in mRNA expression
of CD11c and F480 although expression of proinflammatory
6 Experimental Diabetes Research
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Figure 4: Relative mRNA expression of markers for immune cell
infiltration and oxidative stress is decreased in gonadal adipose
tissue isolated from obese female mice as compared to obese male
mice. Male and female C57BL/6 mice were fed either a standard
rodent chow or a high-fat diet (HFD) from 6 weeks of age
until the HFD-fed group achieved a body weight of 45 g. At that
time, both chow- and HFD-fed males (21weeks old) or females
(38weeks old) were sacrificed and qRT PCR was performed on
gonadal adipose tissue. Relative mRNA expression of markers for
immune cell infiltration and inflammation (a) as well as oxidative
stress (b) was determined. Data are reported as mean ± SE;
n = 5–8 per group; means with diﬀerent superscripts diﬀer by
P < 0.05. IL-6: interleukin-6; MCP-1: monocyte chemoattractant
protein-1; TNF-α: tumor necrosis factor-alpha; eNOS: endothelial
nitric oxide synthase; iNOS: inducible nitric oxide synthase; HO-
1: heme oxygenase-1; p40phox: NADPH subunit p40phox; Prdx1:
peroxiredoxin-1.
cytokines was not diﬀerent between male HFD and female
HFD groups, suggesting that a factor other than these
cytokines was potentially responsible for the improvement in
glucose tolerance.
We then measured mRNA expression of the adipokines
leptin and adiponectin in gonadal adipose tissue. Consistent
with previous studies [29], obesity caused an increase in
leptin expression in both HFD-fed groups. Interestingly,
obesity caused a reduction in adiponectin expression in the
male HFD group, but expression was unchanged with obesity
in the female HFD group. These data are not surprising as
females typically have higher adiponectin levels than males
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Figure 5: Relative mRNA expression of markers for immune
cell infiltration and oxidative stress is altered in subcutaneous
adipose tissue isolated from obese female mice as compared to
obese male mice. Male and female C57BL/6 mice were fed either
a standard rodent chow or a high-fat diet (HFD) from 6 weeks
of age until the HFD-fed group achieved a body weight of 45 g.
At that time, both chow- and HFD-fed males (21weeks old) or
females (38weeks old) were sacrificed and qRT PCR was performed
on subcutaneous adipose tissue. Relative mRNA expression of
markers for immune cell infiltration and inflammation (a) as well
as oxidative stress (b) was determined. Data are reported as mean±
SE; n = 5–8 per group; means with diﬀerent superscripts diﬀer by
P < 0.05. IL-6: interleukin-6; MCP-1: monocyte chemoattractant
protein-1; TNF-α: tumor necrosis factor-alpha; eNOS: endothelial
nitric oxide synthase; iNOS: inducible nitric oxide synthase; HO-
1: heme oxygenase-1; p40phox: NADPH subunit p40phox; Prdx1:
peroxiredoxin-1.
[30, 31] and while this appears to occur independent of
estradiol levels, adiponectin is associated with improved
insulin sensitivity and suggests a potential mechanism
for our observed improvement in the females. However,
additional studies investigating circulating concentrations
of adiponectin are required to more fully explore this
possibility. Endothelial dysfunction and oxidative stress are
additional stressors that can influence glucose metabolism
and were assessed in adipose tissue. Reduced mRNA expres-
sion of eNOS and elevations in HO-1, p40phox, and prdx1
in the adipose tissue of male HFD mice is indicative of
oxidative stress within the tissue [32–35]. Alterations in the
profile of these genes were not as severe in the female HFD
adipose tissue revealing a possible reduction in oxidative
stress and another potential mechanism by which estrogen
may have provided a beneficial eﬀect. Nominal diﬀerences
Experimental Diabetes Research 7
existed between male chow and female chow adipose tissue
and therefore it is unlikely that any of our observations in
the obese cohorts were influenced by baseline diﬀerences.
Overall, our study demonstrates that if provided enough
time, chronic exposure to a hypercaloric diet will induce
an obese phenotype in female mice that is characterized
by excess abdominal adiposity and enlarged adipocytes as
compared to weight-matched obese male mice. However,
despite being an older animal, female mice maintained
partial protection from the detrimental eﬀects of obesity
as demonstrated by improved glucose tolerance testing.
Furthermore, immune cell infiltration and oxidative stress
were reduced in the adipose tissue of obese female mice, and
these changes were associated with increased adiponectin
expression. It is likely that a combination of these factors
is responsible for the observed improvement in glucose
tolerance. While obesity did not alter circulating levels of
estrogen we recognize that estrogen may not be the only
factor influencing the improved phenotype observed in the
female HFD group. However, our data are consistent with
studies that have more carefully manipulated circulating
levels of estrogen. Future studies in weight-matched obese
females will be required to extend and verify these initial
findings.
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